Actively Recruiting

Age: 40Years - 80Years
All Genders
NCT07267104

Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices

Led by Corporacion Parc Tauli · Updated on 2025-12-05

75

Participants Needed

1

Research Sites

88 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will look at people with COPD who use a home breathing machine called non-invasive ventilation (NIV). NIV machines collect information about your breathing, such as air flow, pressure, and mask leaks. Researchers want to use a computer program, called artificial intelligence (AI), to study this information. The goal is to find early signs that your breathing may be getting worse. People with COPD who already use NIV at home may join this study. The study does not change your treatment. It only uses the breathing data already recorded by your NIV machine. The computer program will look for patterns in the data. These patterns may help doctors: Notice early warning signs of a COPD flare-up Find problems with how you and the machine work together Improve the way NIV is monitored at home The main goal is to create a tool that helps patients and doctors manage home NIV more easily and more safely.

CONDITIONS

Official Title

Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices

Who Can Participate

Age: 40Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 40 and 80 years
  • COPD diagnosed by pulmonary function tests
  • Using home NIV therapy with good adherence (minimum daily use over 5 hours) for at least 6 months
  • Using the ResMed LUMIS 150 ventilator
  • Experiencing an acute exacerbation requiring hospital admission or home care
Not Eligible

You will not qualify if you...

  • Lack of informed consent
  • Clinical instability defined by need for antibiotics and/or systemic corticosteroids within 2 months prior to inclusion exacerbation, excluding 48 hours before admission

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Corporation Parc Tauli de Sabadell

Sabadell, Barcelona, Spain

Actively Recruiting

Loading map...

Research Team

M

Manel Lujan, Professor MD pHD

CONTACT

C

Cristina Lalmolda Puyol, RT phD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here